Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.

Arbore G, West EE, Spolski R, Robertson AA, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O'Neill LA, Coll RC, Sher A, Leonard WJ, Köhl J, Monk P, Cooper MA, Arno M, Afzali B, Lachmann HJ, Cope AP, Mayer-Barber KD, Kemper C.

Science. 2016 Jun 17;352(6292):aad1210. doi: 10.1126/science.aad1210.

PMID:
27313051
2.

Bayesian cluster identification in single-molecule localization microscopy data.

Rubin-Delanchy P, Burn GL, Griffié J, Williamson DJ, Heard NA, Cope AP, Owen DM.

Nat Methods. 2015 Nov;12(11):1072-6. doi: 10.1038/nmeth.3612. Epub 2015 Oct 5.

PMID:
26436479
3.

Correction. Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus.

Fraser LD, Zhao Y, Lutalo PM, D'Cruz DP, Cason J, Silva JS, Dunn-Walters DK, Nayar S, Cope AP, Spencer J.

Eur J Immunol. 2015 Sep;45(9):2701. doi: 10.1002/eji.201570097. No abstract available.

PMID:
26343565
4.

Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus.

Fraser LD, Zhao Y, Lutalo PM, D'Cruz DP, Cason J, Silva JS, Dunn-Walters DK, Nayar S, Cope AP, Spencer J.

Eur J Immunol. 2015 Aug;45(8):2409-19. doi: 10.1002/eji.201545599. Epub 2015 Jun 24. Erratum in: Eur J Immunol. 2015 Sep;45(9):2701.

5.

The ying and yang of fever in rheumatic disease.

Galloway J, Cope AP.

Clin Med (Lond). 2015 Jun;15(3):288-91. doi: 10.7861/clinmedicine.15-3-288.

PMID:
26031982
6.

Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?

Scott IC, Rijsdijk F, Walker J, Quist J, Spain SL, Tan R, Steer S, Okada Y, Raychaudhuri S, Cope AP, Lewis CM.

J Rheumatol. 2015 Jul;42(7):1131-40. doi: 10.3899/jrheum.141211. Epub 2015 May 15.

PMID:
25979711
7.

Improving medication adherence in rheumatoid arthritis (RA): a pilot study.

Ferguson A, Ibrahim FA, Thomas V, Weinman J, Simpson C, Cope AP, Scott DL, Lempp H.

Psychol Health Med. 2015;20(7):781-9. doi: 10.1080/13548506.2015.1009917. Epub 2015 Mar 16.

PMID:
25774559
8.

Immunoglobulin kappa variable region gene selection during early human B cell development in health and systemic lupus erythematosus.

Hehle V, Fraser LD, Tahir R, Kipling D, Wu YC, Lutalo PM, Cason J, Choong L, D'Cruz DP, Cope AP, Dunn-Walters DK, Spencer J.

Mol Immunol. 2015 Jun;65(2):215-23. doi: 10.1016/j.molimm.2015.01.017. Epub 2015 Feb 17.

PMID:
25700344
9.

Topographic prominence as a method for cluster identification in single-molecule localisation data.

Griffié J, Boelen L, Burn G, Cope AP, Owen DM.

J Biophotonics. 2015 Nov;8(11-12):925-34. doi: 10.1002/jbio.201400127. Epub 2015 Feb 6.

PMID:
25663080
10.

Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.

Ma MH, Scott IC, Dahanayake C, Cope AP, Scott DL.

J Rheumatol. 2014 Jul;41(7):1298-303. doi: 10.3899/jrheum.131401.

PMID:
24931951
11.

TNF-α blockade induces IL-10 expression in human CD4+ T cells.

Evans HG, Roostalu U, Walter GJ, Gullick NJ, Frederiksen KS, Roberts CA, Sumner J, Baeten DL, Gerwien JG, Cope AP, Geissmann F, Kirkham BW, Taams LS.

Nat Commun. 2014;5:3199. doi: 10.1038/ncomms4199.

12.

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.

Seegobin SD, Ma MH, Dahanayake C, Cope AP, Scott DL, Lewis CM, Scott IC.

Arthritis Res Ther. 2014 Jan 16;16(1):R13. doi: 10.1186/ar4439.

13.

Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking.

Scott IC, Seegobin SD, Steer S, Tan R, Forabosco P, Hinks A, Eyre S, Morgan AW, Wilson AG, Hocking LJ, Wordsworth P, Barton A, Worthington J, Cope AP, Lewis CM.

PLoS Genet. 2013;9(9):e1003808. doi: 10.1371/journal.pgen.1003808. Epub 2013 Sep 19. Erratum in: PLoS Genet. 2013 Oct;9(10). doi:10.1371/annotation/a86ab397-f58c-4144-a241-4957836a728a.

14.

CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner.

Afzali B, Mitchell PJ, Edozie FC, Povoleri GA, Dowson SE, Demandt L, Walter G, Canavan JB, Scotta C, Menon B, Chana PS, Khamri W, Kordasti SY, Heck S, Grimbacher B, Tree T, Cope AP, Taams LS, Lechler RI, John S, Lombardi G.

Eur J Immunol. 2013 Aug;43(8):2043-54. doi: 10.1002/eji.201243296. Epub 2013 Jul 3.

15.

Adding new perspectives to the kaleidoscope of remission criteria in rheumatoid arthritis.

Ma MH, Cope AP, Scott DL.

J Rheumatol. 2013 Apr;40(4):353-5. doi: 10.3899/jrheum.130099. No abstract available.

PMID:
23547254
16.

The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis.

Scott IC, Tan R, Stahl D, Steer S, Lewis CM, Cope AP.

Rheumatology (Oxford). 2013 May;52(5):856-67. doi: 10.1093/rheumatology/kes376. Epub 2013 Jan 3. Review.

17.

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Walter GJ, Evans HG, Menon B, Gullick NJ, Kirkham BW, Cope AP, Geissmann F, Taams LS.

Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.

18.

Signal transduction pathways in chronic inflammatory rheumatic diseases.

Cope AP.

Open Rheumatol J. 2012;6:207-8. Epub 2012 Sep 7. No abstract available.

19.

Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation.

Nicolaidou V, Wong MM, Redpath AN, Ersek A, Baban DF, Williams LM, Cope AP, Horwood NJ.

PLoS One. 2012;7(7):e39871. doi: 10.1371/journal.pone.0039871. Epub 2012 Jul 3.

20.

CD3ζ-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation.

Érsek B, Molnár V, Balogh A, Matkó J, Cope AP, Buzás EI, Falus A, Nagy G.

J Immunol. 2012 Aug 15;189(4):1602-10. doi: 10.4049/jimmunol.1102365. Epub 2012 Jul 13.

Items per page

Supplemental Content

Write to the Help Desk